Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review)
International Journal of Oncology · 2023
DOI: 10.3892/ijo.2023.5510 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Oncology, 2023. Verfasst von Kailiang Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Lab…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education…
Zitieren
APA
Wu, K., Niu, C., Liu, H., & Fu, L. (2023). Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.2023.5510
Vancouver
Wu K, Niu C, Liu H, Fu L. Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review). International Journal of Oncology. 2023. doi:10.3892/ijo.2023.5510
BibTeX
@article{Wu2023,
author = {Wu, Kailiang and Niu, Chen and Liu, Hanjiao and Fu, Li},
title = {Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review)},
journal = {International Journal of Oncology},
year = {2023},
doi = {10.3892/ijo.2023.5510}
}
EUVIMED